Global Eosinophilic Esophagitis Drug Market Research Report 2018

February 2018 | 128 pages | ID: GAFA8625CD3EN
QYResearch

Abstracts

This report studies the Eosinophilic Esophagitis Drug market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the Eosinophilic Esophagitis Drug market by product type and applications/end industries.

In the last several years, global market of eosinophilic esophagitis drug developed smoothly, with an average growth rate of 3.73%. In 2017, global revenue of eosinophilic esophagitis drug is nearly 103 M USD.

The major players in global Eosinophilic Esophagitis Drug market include

• AstraZeneca
• GSK
• Bayer
• Adare Pharmaceuticals
• DBV Technologies
• Dr. Falk Pharma
• Quorum Innovations
• Shire
• Calypso
• Celgene
• Regeneron

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth rate of Eosinophilic Esophagitis Drug in these regions, from 2013 to 2025 (forecast), covering

• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

On the basis of product, the Eosinophilic Esophagitis Drug market is primarily split into

• Budesonide
• Fluticasone
• Others

On the basis of product pipeline, the Eosinophilic Esophagitis Drug market is primarily split into

• APT-1011
• Viaskin Milk
• Budesonide effervescent tablets
• Qi-201
• SHP621
• CALY-002
• RPC4046
• Dupilumab

On the basis on the end users/applications, this report covers

• Hospitals
• Clinics
• Drugstore

Contents

1 EOSINOPHILIC ESOPHAGITIS DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Eosinophilic Esophagitis Drug
1.2 Eosinophilic Esophagitis Drug Segment by Types (Product Category)
  1.2.1 Global Eosinophilic Esophagitis Drug Sales by Types
  1.2.2 Global Eosinophilic Esophagitis Drug Sales Market Share by Types in 2017
  1.2.3 Budesonide
  1.2.4 Fluticasone
1.3 Global Eosinophilic Esophagitis Drug Segment by Applications
1.4 Global Eosinophilic Esophagitis Drug Market by Regions (2013-2025)
  1.4.1 Global Eosinophilic Esophagitis Drug Market Size and Growth (%) Comparison by Regions (2013-2025)
  1.4.2 North America Eosinophilic Esophagitis Drug Status and Prospect (2013-2025)
  1.4.3 Asia-Pacific Eosinophilic Esophagitis Drug Status and Prospect (2013-2025)
  1.4.4 Europe Eosinophilic Esophagitis Drug Status and Prospect (2013-2025)
  1.4.5 South America Eosinophilic Esophagitis Drug Status and Prospect (2013-2025)
  1.4.6 Middle East and Africa Eosinophilic Esophagitis Drug Status and Prospect (2013-2025)
1.5 Global Eosinophilic Esophagitis Drug Market Size (2013-2025)
  1.5.1 Global Eosinophilic Esophagitis Drug Revenue Status and Outlook (2013-2025)
  1.5.2 Global Eosinophilic Esophagitis Drug Sales Status and Outlook (2013-2025)

2 GLOBAL EOSINOPHILIC ESOPHAGITIS DRUG MARKET COMPETITION BY MANUFACTURERS/BRAND

2.1 Global Eosinophilic Esophagitis Drug Sales and Share by Manufacturers (2017-2018)
2.2 Global Eosinophilic Esophagitis Drug Revenue and Share by Manufacturers (2017-2018)
2.3 Global Eosinophilic Esophagitis Drug Average Price by Manufacturers (2017-2018)
2.4 Manufacturers Eosinophilic Esophagitis Drug Headquarters, Established Date and Product Brand
2.5 Eosinophilic Esophagitis Drug Market Competitive Situation and Trends
  2.5.1 Eosinophilic Esophagitis Drug Market Concentration Rate
  2.5.2 Eosinophilic Esophagitis Drug Market Share of Top 3 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL EOSINOPHILIC ESOPHAGITIS DRUG SALES, REVENUE BY REGIONS (2013-2018)

3.1 Global Eosinophilic Esophagitis Drug Sales and Market Share by Regions (2013-2018)
3.2 Global Eosinophilic Esophagitis Drug Revenue and Market Share by Regions (2013-2018)
3.3 Global Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
3.4 North America Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
3.5 Europe Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
3.6 Asia-Pacific Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
3.7 South America Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
3.8 Middle East and Africa Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)

4 GLOBAL EOSINOPHILIC ESOPHAGITIS DRUG SALES, REVENUE, PRICE TREND BY TYPES

4.1 Global Eosinophilic Esophagitis Drug Sales and Market Share by Types (2013-2018)
4.2 Global Eosinophilic Esophagitis Drug Revenue and Market Share by Types (2013-2018)
4.3 Global Eosinophilic Esophagitis Drug Price by Type (2013-2018)
4.4 Global Eosinophilic Esophagitis Drug Sales Growth by Type (2013-2018)

5 GLOBAL EOSINOPHILIC ESOPHAGITIS DRUG MARKET ANALYSIS BY APPLICATIONS

5.1 Global Eosinophilic Esophagitis Drug Sales and Market Share by Applications (2013-2018)
5.2 Global Eosinophilic Esophagitis Drug Sales Growth Rate by Applications (2013-2018)

6 ANALYSIS OF EOSINOPHILIC ESOPHAGITIS DRUG INDUSTRY KEY MANUFACTURERS

6.1 AstraZeneca
  6.1.1 Company Profile
  6.1.2 Product Information
  6.1.3 Sales, Price, Cost, Gross, and Revenue
6.2 GSK
  6.2.1 Company Profile
  6.2.2 Product Information
  6.2.3 Sales, Price, Cost, Gross, and Revenue
6.3 Bayer
  6.3.1 Company Profile
  6.3.2 Product Information
  6.3.3 Sales, Price, Cost, Gross, and Revenue
6.4 Adare Pharmaceuticals
  6.4.1 Company Profile
  6.4.2 Product Information
6.5 DBV Technologies
  6.5.1 Company Profile
  6.5.2 Product Information
6.6 Dr. Falk Pharma
  6.6.1 Company Profile
  6.6.2 Product Information
6.7 Quorum Innovations
  6.7.1 Company Profile
  6.7.2 Product Information
6.8 Shire
  6.8.1 Company Profile
  6.8.2 Product Information
6.9 Calypso
  6.9.1 Company Profile
  6.9.2 Product Information
6.10 Celgene
  6.10.1 Company Profile
  6.10.2 Product Information
6.11 Regeneron
  6.11.1 Company Profile
  6.11.2 Product Information

7 EOSINOPHILIC ESOPHAGITIS DRUG MANUFACTURING COST ANALYSIS

7.1 Eosinophilic Esophagitis Drug R&D Cost Analysis
  7.1.1 Clinical Phase Costs
  7.1.2 Capitalized Costs
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
    7.2.2.1 USA Labor Cost Analysis
    7.2.2.2 Europe Labor Costs Analysis
    7.2.2.3 Asia Labor Costs Analysis
  7.2.3 Other Costs Analysis
    7.2.3.1 USA Cost of Electricity Analysis
    7.2.3.2 USA Water Cost Analysis
    7.2.3.3 Europe Cost of Electricity Analysis
    7.2.3.4 Europe Water Cost Analysis
    7.2.3.5 China Cost of Electricity Analysis
    7.2.3.6 China Water Cost Analysis
  7.2.4 Manufacturing Expenses

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Eosinophilic Esophagitis Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress
  10.1.1 Eosinophilic Esophagitis Drug Pipeline
  10.1.2 Eosinophilic Esophagitis Drug Introudction
    10.1.2.1 APT-1011
    10.1.2.2 Viaskin Milk
    10.1.2.3 Budesonide Effervescent Tablets
    10.1.2.4 SHP621
    10.1.2.5 Dupilumab
    10.1.2.6 CALY-002
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 GLOBAL EOSINOPHILIC ESOPHAGITIS DRUG MARKET FORECAST (2019-2025)

11.1 Global Eosinophilic Esophagitis Drug Sales, Revenue Forecast (2019-2025)
  11.1.1 Global Eosinophilic Esophagitis Drug Sales and Growth Rate Forecast (2019-2025)
  11.1.2 Global Eosinophilic Esophagitis Drug Revenue and Growth Rate Forecast (2019-2025)
11.2 Global and Europe Eosinophilic Esophagitis Drug Sales and Revenue Forecast by Regions (2019-2025)
  11.2.1 Global Eosinophilic Esophagitis Drug Sales and Revenue Forecast by Regions (2019-2025)
  11.2.2 North America Eosinophilic Esophagitis Drug Sales and Revenue Forecast (2019-2025)
  11.2.3 Europe Eosinophilic Esophagitis Drug Sales and Revenue Forecast (2019-2025)
  11.2.4 Asia-Pacific Eosinophilic Esophagitis Drug Sales and Revenue Forecast (2019-2025)
  11.2.5 South America Eosinophilic Esophagitis Drug Sales and Revenue Forecast (2019-2025)
  11.2.6 Middle East and Africa Eosinophilic Esophagitis Drug Sales and Revenue Forecast (2019-2025)
11.3 Global Eosinophilic Esophagitis Drug Sales Forecast by Type (2019-2025)
11.4 Global Eosinophilic Esophagitis Drug Sales Forecast by Application (2019-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Eosinophilic Esophagitis Drug
Table Classification of Eosinophilic Esophagitis Drug
Table Global Eosinophilic Esophagitis Drug Sales (K Units) and Growth Rate (%) Comparison by Types (2013-2025)
Figure Global Eosinophilic Esophagitis Drug Sales Market Share (%) by Types in 2017
Figure Product Picture of Budesonide
Figure Product Picture of Fluticasone
Table Global Eosinophilic Esophagitis Drug Sales (K Units) and Growth Rate (%) Comparison by Applications (2013-2025)
Figure Global Eosinophilic Esophagitis Drug Sales Market Share by Applications in 2017
Table Global Market Eosinophilic Esophagitis Drug Revenue (M USD) Comparison by Regions 2013-2025
Figure North America Eosinophilic Esophagitis Drug Revenue (M USD) and Growth Rate (%) (2013-2025)
Figure Asia-Pacific Eosinophilic Esophagitis Drug Revenue (M USD) and Growth Rate (%) (2013-2025)
Figure Europe Eosinophilic Esophagitis Drug Revenue (M USD) and Growth Rate (%) (2013-2025)
Figure South America Eosinophilic Esophagitis Drug Revenue (M USD) and Growth Rate (%) (2013-2025)
Figure Middle East and Africa Eosinophilic Esophagitis Drug Revenue (M USD) and Growth Rate (%) (2013-2025)
Figure Global Eosinophilic Esophagitis Drug Revenue (M USD) Status and Outlook (2013-2025)
Figure Global Eosinophilic Esophagitis Drug Sales (K Units) Status and Outlook (2013-2025)
Table Global Eosinophilic Esophagitis Drug Sales (K Units) of Key Manufacturers (2017-2018)
Table Global Eosinophilic Esophagitis Drug Sales Share (%) by Manufacturers (2017-2018)
Figure 2017 Eosinophilic Esophagitis Drug Sales Share (%) by Manufacturers
Figure 2018 Eosinophilic Esophagitis Drug Sales Share (%) by Manufacturers
Table Global Eosinophilic Esophagitis Drug Revenue (M USD) by Manufacturers (2017-2018)
Table Global Eosinophilic Esophagitis Drug Revenue Share (%) by Manufacturers (2017-2018)
Figure 2017 Global Eosinophilic Esophagitis Drug Revenue Share (%) by Manufacturers
Figure 2018 Global Eosinophilic Esophagitis Drug Revenue Share (%) by Manufacturers
Table Global Market Eosinophilic Esophagitis Drug Average Price (USD/Unit) of Key Manufacturers (2017-2018)
Figure Global Market Eosinophilic Esophagitis Drug Average Price (USD/Unit) of Key Manufacturers in 2017
Table Manufacturers Eosinophilic Esophagitis Drug Headquarters and Established Date
Table Manufacturers Eosinophilic Esophagitis Drug Brand
Figure Eosinophilic Esophagitis Drug Revenue Market Concentration Rate in 2017
Figure Eosinophilic Esophagitis Drug Revenue Market Share (%) of Top 3 Manufacturers in 2017
Table Mergers & Acquisitions, Expansion
Table Global Eosinophilic Esophagitis Drug Sales (K Units) by Regions (2013-2018)
Table Global Eosinophilic Esophagitis Drug Sales Market Share (%) by Regions (2013-2018)
Figure Global Eosinophilic Esophagitis Drug Sales Market Share (%) by Regions (2013-2018)
Figure 2017 Global Eosinophilic Esophagitis Drug Sales Market Share (%) by Regions
Table Global Eosinophilic Esophagitis Drug Revenue (M USD) by Regions (2013-2018)
Table Global Eosinophilic Esophagitis Drug Revenue Market Share (%) by Regions (2013-2018)
Figure Global Eosinophilic Esophagitis Drug Revenue Market Share by Regions (2013-2018)
Figure 2017 Global Eosinophilic Esophagitis Drug Revenue Market Share by Regions
Table Global Eosinophilic Esophagitis Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (%) (2013-2018)
Table North America Eosinophilic Esophagitis Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (%) (2013-2018)
Table Europe Eosinophilic Esophagitis Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (%) (2013-2018)
Table Asia-Pacific Eosinophilic Esophagitis Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (%) (2013-2018)
Table South America Eosinophilic Esophagitis Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (%) (2013-2018)
Table Middle East and Africa Eosinophilic Esophagitis Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (%) (2013-2018)
Table Global Eosinophilic Esophagitis Drug Sales (K Units) by Types (2013-2018)
Table Global Eosinophilic Esophagitis Drug Sales Share (%) by Types (2013-2018)
Figure Sales Market Share (%) of Eosinophilic Esophagitis Drug by Types (2013-2018)
Figure 2017 Sales Market Share (%) of Eosinophilic Esophagitis Drug by Types
Table Global Eosinophilic Esophagitis Drug Revenue (M USD) by Types (2013-2018)
Table Global Eosinophilic Esophagitis Drug Revenue Share (%) by Types (2013-2018)
Figure Revenue Share of Eosinophilic Esophagitis Drug by Types (2013-2018)
Figure 2017 Revenue Market Share (%) of Eosinophilic Esophagitis Drug by Types
Table Global Eosinophilic Esophagitis Drug Price (USD/Unit) by Types (2013-2018)
Figure Global Eosinophilic Esophagitis Drug Sales Growth (%) by Type (2013-2018)
Table Global Eosinophilic Esophagitis Drug Sales (K Units) by Applications (2013-2018)
Table Global Eosinophilic Esophagitis Drug Sales Market Share (%) by Applications (2013-2018)
Figure Global Eosinophilic Esophagitis Drug Sales Market Share (%) by Applications (2013-2018)
Figure Global Eosinophilic Esophagitis Drug Sales Market Share (%) by Applications in 2017
Table Global Eosinophilic Esophagitis Drug Sales Growth Rate (%) by Applications (2013-2018)
Figure Global Eosinophilic Esophagitis Drug Sales Growth Rate (%) by Applications (2013-2018)
Table AstraZeneca Company Profile
Table Eosinophilic Esophagitis Drug Product Information of AstraZeneca
Table Eosinophilic Esophagitis Drug Sales (K Units), Price (USD/Unit), Revenue (M USD) and Gross Margin of AstraZeneca (2017 and 2018)
Table GSK Company Profile
Table Eosinophilic Esophagitis Drug Product Information of GSK
Table Eosinophilic Esophagitis Drug Sales (K Units), Price (USD/Unit), Revenue (M USD) and Gross Margin of GSK (2017 and 2018)
Table Bayer Company Profile
Table Eosinophilic Esophagitis Drug Product Information of Bayer
Table Eosinophilic Esophagitis Drug Sales (K Units), Price (USD/Unit), Revenue (M USD) and Gross Margin of Bayer (2017 and 2018)
Table Adare Pharmaceuticals Company Profile
Table Eosinophilic Esophagitis Drug Product Information of Adare Pharmaceuticals
Table DBV Technologies Company Profile
Table Eosinophilic Esophagitis Drug Product Information of DBV Technologies
Table Dr. Falk Pharma Company Profile
Table Eosinophilic Esophagitis Drug Product Information of Dr. Falk Pharma
Table Quorum Innovations Company Profile
Figure Eosinophilic Esophagitis Drug Product Information of Quorum Innovations
Table Shire Company Profile
Table Eosinophilic Esophagitis Drug Product Information of Shire
Table Calypso Company Profile
Table Eosinophilic Esophagitis Drug Product Information of Calypso
Table Celgene Company Profile
Table Eosinophilic Esophagitis Drug Product Information of Celgene
Table Regeneron Company Profile
Table Eosinophilic Esophagitis Drug Product Information of Regeneron
Figure typical phases from research to the market for a drug candidate
Table Out-of-pocket Preclinical and Clinical Period Cost Per Investigational Biopharmaceutical Compound
Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound
Figure Manufacturing Cost Structure of Eosinophilic Esophagitis Drug
Figure Assessment of API Manufacturing Cost by Region
Figure USA Labor Cost Analysis 2012-2016
Figure Cost of Employing a Factory Worker
Figure 2016 Estimated Labour Costs for the Whole Economy in Europe
Figure Monthly Minimum Wages in Asia 2016
Figure China Labor Costs 2013-2016
Table Average Price of Electricity to Ultimate Customers 2007-2016
Figure Electricity Prices for Household Consumers in 2016
Figure Summary of the Driving Assumptions
Figure Industrial Electric Rates 2016 (PER KWH)
Figure Eosinophilic Esophagitis Drug Industrial Chain Analysis
Table Major Buyers of Eosinophilic Esophagitis Drug
Figure Setting Pricing Policy
Table Distributors/Traders List
Table Eosinophilic Esophagitis Drug Pipeline
Figure Global GDP Growth Rate for 2016
Figure Real GDP Growth 2016-2020 annual Average
Figure US GDP 2006-2016 (Billion USD)
Figure US CPI Change 2017-2018
Figure EU GDP 2008-2016 (Billion USD)
Figure EU CPI Change 2017
Figure Germany GDP 2008-2016 (Billion USD)
Figure Germany CPI Change 2017-2018
Figure UK GDP 2008-2016 (Billion USD)
Figure UK CPI Change 2016-2017
Figure Italy GDP 2008-2016 (Billion USD)
Figure Italy CPI Change 2017-2018
Figure Japan GDP 2008-2016 (Billion USD)
Figure Japan CPI Change 2017
Figure China GDP 2008-2016 (Billion USD)
Figure China CPI Change 2017-2018
Figure Global Eosinophilic Esophagitis Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Global Eosinophilic Esophagitis Drug Revenue (M USD) and Growth Rate (%) Forecast (2019-2025)
Table Global Eosinophilic Esophagitis Drug Sales (K Units) Forecast by Regions (2019-2025)
Figure Global Eosinophilic Esophagitis Drug Sales Market Share Forecast by Regions (2019-2025)
Figure North America Eosinophilic Esophagitis Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure North America Eosinophilic Esophagitis Drug Revenue (M USD) and Growth Rate (%) Forecast (2019-2025)
Figure Europe Eosinophilic Esophagitis Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Europe Eosinophilic Esophagitis Drug Revenue (M USD) and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific Eosinophilic Esophagitis Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific Eosinophilic Esophagitis Drug Revenue (M USD) and Growth Rate (%) Forecast (2019-2025)
Figure South America Eosinophilic Esophagitis Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure South America Eosinophilic Esophagitis Drug Revenue (M USD) and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa Eosinophilic Esophagitis Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa Eosinophilic Esophagitis Drug Revenue (M USD) and Growth Rate (%) Forecast (2019-2025)
Table Global Eosinophilic Esophagitis Drug Sales (K Units) Forecast by Type (2019-2025)
Figure Global Eosinophilic Esophagitis Drug Sales Market Share (%) Forecast by Type (2019-2025)
Table Global Eosinophilic Esophagitis Drug Sales (K Units) Forecast by Application (2019-2025)
Figure Global Eosinophilic Esophagitis Drug Sales Forecast by Application (2019-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources